Stratasys SSYS recently announced the launch of a new software module — Digital Anatomy Creator — designed for its Digital Anatomy 3D Printers to enhance personalized healthcare through anatomic modeling solutions.
The software enables healthcare providers to easily manipulate material formations and customize their prints’ eternal structures for patient-specific anatomic models, which are a replication of the patient’s pathologic and biologic anatomy.
With the Digital Anatomy Creator, the users will be able to create, explore and share ultra-realistic designs of patient-specific anatomies across communities. They will be able to access additional options and controls to calibrate printing materials, thus fulfilling user-specific, personalised, anatomic model requirements.
Stratasys collaborated with Synopsys’ SNPS Simpleware ScanIP Medical and Materialise’s MTLS Mimics inPrint to certify its Digital Anatomy and J5 MediJet printers to be included in FDA 510(k) cleared medical modeling workflows. This will give customers access to digital workflows for diagnostic anatomic modeling and enhance point-of-care 3D printing.
Of late, Stratasys has been expanding its materials ecosystem across P3, Selective Absorption Fusion (“SAF”), and stereolithography 3D printing systems. Recently, in November, it launched an Open Material License to advance its manufacturing strategy with a new open tier of third-party materials for FDM 3D printers. This enabled its manufacturing customers to address new applications with demanding requirements, while having dual material sources.
In October, Stratasys introduced GrabCAD Additive Manufacturing Platform, an open and enterprise-ready software platform that enables manufacturers to manage production-scale additive manufacturing operations.
In September, the company introduced an Open Material License for the P3-based Origin One along with two new materials from Loctite by Henkel. Earlier, in June, it expanded its software ecosystem with the addition of Teton Simulation, which utilizes GrabCAD DFAM Software Development Kit to help customers improve the reliability of additive manufacturing builds.
Stratasys, Ltd. Price and Consensus
Stratasys, Ltd. price-consensus-chart | Stratasys, Ltd. Quote
Zacks Rank & Stocks to Consider
Stratasys and Synonpsys currently carry a Zacks Rank #3 (Hold), while Materialise sports a Zacks Rank #1 (Strong Buy). Shares of SSYS and SNPS have appreciated 30.4% and 37.3%, respectively, while MTLS has depreciated 56.1% in the year-to-date (“YTD”) period.
A better-ranked stock in the broader technology sector includes Advanced Micro Devices AMD, which carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Advanced Micro Devices’ fourth-quarter 2021 earnings has been revised upward by 8 cents to 76 cents per share over the past 60 days. For 2021, earnings estimates moved north by 15 cents to $2.65 per share in the last 60 days.
Advanced Micro Devices’ earnings beat the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 14%. Shares of AMD have rallied 76.5% in the YTD period.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Advanced Micro Devices, Inc. (AMD) : Free Stock Analysis Report
Stratasys, Ltd. (SSYS) : Free Stock Analysis Report
Synopsys, Inc. (SNPS) : Free Stock Analysis Report
Materialise NV (MTLS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research